Index RUT P/E - EPS (ttm) -0.10 Insider Own 42.35% Shs Outstand 126.59M Perf Week -0.08%
Market Cap 3.11B Forward P/E 19.48 EPS next Y 1.26 Insider Trans -37.03% Shs Float 72.99M Perf Month -9.32%
Income -11.90M PEG - EPS next Q 0.07 Inst Own 66.33% Short Float 11.78% Perf Quarter -24.36%
Sales 2.74B P/S 1.13 EPS this Y -1.67% Inst Trans 0.52% Short Ratio 9.49 Perf Half Y 8.30%
Book/sh 15.70 P/B 1.56 EPS next Y 28.08% ROA -0.17% Short Interest 8.60M Perf Year -33.29%
Cash/sh 1.55 P/C 15.85 EPS next 5Y 45.50% ROE -0.60% 52W Range 22.05 - 45.79 Perf YTD -23.32%
Dividend Est. - P/FCF 15.15 EPS past 5Y 54.69% ROI -0.24% 52W High -46.43% Beta 2.74
Dividend TTM - Quick Ratio 1.57 Sales past 5Y 9.35% Gross Margin 19.30% 52W Low 11.25% ATR (14) 1.01
Dividend Ex-Date - Current Ratio 1.71 EPS Y/Y TTM 83.53% Oper. Margin 14.89% RSI (14) 38.95 Volatility 3.62% 3.84%
Employees 13500 Debt/Eq 1.54 Sales Y/Y TTM 8.03% Profit Margin -0.43% Recom 1.36 Target Price 42.36
Option/Short Yes / Yes LT Debt/Eq 1.48 EPS Q/Q 96.52% Payout - Rel Volume 0.98 Prev Close 25.00
Sales Surprise -0.82% EPS Surprise 16.22% Sales Q/Q 4.00% Earnings May 07 BMO Avg Volume 906.53K Price 24.53
SMA20 -3.17% SMA50 -11.95% SMA200 -20.13% Trades
Volume 884,671 Change -1.88%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Initiated Barclays
Equal Weight
$35
Nov-14-23 Upgrade TD Cowen
Market Perform → Outperform
$39 → $35
Jun-02-23 Upgrade BofA Securities
Neutral → Buy
$42 → $45
May-12-23 Initiated Mizuho
Buy
$48
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$43
Nov-23-22 Reiterated RBC Capital Mkts
Outperform
$58 → $48
Jun-15-22 Downgrade BofA Securities
Buy → Neutral
$55 → $36
Jan-10-22 Resumed Citigroup
Buy
$58 → $65
Nov-30-21 Initiated Barclays
Overweight
$73
Nov-29-21 Upgrade Stifel
Hold → Buy
$51
Nov-01-21 Initiated JP Morgan
Neutral
$50
Oct-18-21 Initiated SVB Leerink
Outperform
$50
Sep-10-21 Initiated Cowen
Market Perform
$50
Jun-23-21 Resumed Stifel
Hold
$61
Sep-17-20 Reiterated The Benchmark Company
Buy
$23 → $28
Apr-27-20 Upgrade The Benchmark Company
Hold → Buy
$14
Mar-03-20 Downgrade The Benchmark Company
Buy → Hold
Jan-14-20 Reiterated The Benchmark Company
Buy
$13 → $19
Nov-16-18 Initiated UBS
Neutral
$15
Sep-18-18 Upgrade BofA/Merrill
Neutral → Buy
Show Previous Ratings
Apr-30-24 10:01AM
Apr-24-24 08:23AM
07:50AM
Apr-18-24 01:06AM
Mar-26-24 03:51PM
08:21AM
Loading…
08:21AM
Mar-20-24 12:00PM
08:11AM
Mar-06-24 11:55PM
Mar-01-24 08:12AM
Feb-28-24 09:55AM
Feb-26-24 10:59PM
(Thomson Reuters StreetEvents) -8.60%
09:30AM
08:40AM
07:52AM
07:41AM
Loading…
07:41AM
(Associated Press Finance)
07:30AM
Feb-25-24 11:49AM
Feb-21-24 09:15AM
Feb-15-24 05:50AM
Feb-08-24 04:05PM
Feb-07-24 09:09AM
Feb-05-24 12:10PM
Jan-22-24 07:17AM
Jan-08-24 07:30AM
Jan-05-24 01:40PM
Dec-22-23 01:01PM
Dec-14-23 04:33PM
Dec-08-23 05:33AM
05:26AM
09:17AM
Loading…
Dec-06-23 09:17AM
Nov-08-23 04:36PM
Nov-07-23 09:30AM
08:14AM
07:43AM
(Associated Press Finance)
07:30AM
Nov-06-23 07:40AM
Oct-31-23 10:01AM
Oct-11-23 12:09PM
11:40AM
Oct-06-23 03:29PM
Sep-20-23 08:05AM
06:24AM
Sep-06-23 05:01PM
Aug-30-23 07:18AM
Aug-29-23 10:51AM
Aug-17-23 09:35AM
Aug-15-23 06:27AM
Aug-09-23 09:12AM
Aug-01-23 03:10PM
(Investor's Business Daily)
09:30AM
08:55AM
07:48AM
07:30AM
Jul-19-23 08:32PM
Jun-15-23 06:09AM
Jun-14-23 05:00PM
(Investor's Business Daily) +5.04%
May-16-23 07:39AM
May-04-23 10:16AM
May-02-23 09:42AM
(Thomson Reuters StreetEvents) -5.61%
May-01-23 05:35PM
04:23PM
04:01PM
Apr-19-23 06:45AM
06:00AM
Mar-29-23 04:40PM
11:58AM
Mar-02-23 09:20PM
06:35AM
Mar-01-23 09:05AM
07:40AM
Feb-28-23 04:05PM
(Investor's Business Daily)
Feb-09-23 04:15PM
Jan-11-23 09:40AM
Jan-09-23 07:30AM
Jan-03-23 04:10PM
Dec-27-22 10:51AM
Nov-21-22 09:52AM
06:09AM
06:00AM
Nov-10-22 05:53AM
(Simply Wall St.) +29.55%
Nov-09-22 11:04AM
05:40AM
Nov-08-22 08:55AM
07:40AM
Oct-10-22 04:23PM
Sep-19-22 09:14AM
Aug-03-22 07:25AM
Aug-02-22 02:30PM
08:55AM
07:30AM
Jun-29-22 04:15PM
Jun-19-22 09:18AM
Jun-16-22 08:51AM
Jun-02-22 04:50PM
May-04-22 06:19PM
May-03-22 01:20PM
(American City Business Journals) +7.20%
01:00PM
09:00AM
08:45AM
Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Doherty David T Chief Financial Officer Mar 14 '24 Sale 28.59 721 20,613 95,719 Mar 15 05:09 PM Evans Jason Eric Chief Executive Officer Mar 13 '24 Sale 29.71 4,840 143,796 459,670 Mar 13 04:49 PM Owens Bradley R. National Group President Mar 12 '24 Sale 29.82 2,783 82,989 78,338 Mar 13 04:41 PM Baldock Jennifer Chief Admin & Dev Officer Mar 12 '24 Sale 29.74 922 27,420 183,644 Mar 13 04:40 PM TAPARO ANTHONY Chief Growth Officer Mar 12 '24 Sale 29.87 787 23,508 102,321 Mar 13 04:40 PM Burkhalter Danielle Chief Human Resources Officer Mar 12 '24 Sale 29.74 111 3,301 36,354 Mar 13 04:41 PM Evans Jason Eric Chief Executive Officer Mar 11 '24 Sale 29.44 1,984 58,409 464,510 Mar 13 04:49 PM Baldock Jennifer Chief Admin & Dev Officer Mar 11 '24 Sale 29.70 675 20,048 184,566 Mar 13 04:40 PM TAPARO ANTHONY Chief Growth Officer Mar 11 '24 Sale 29.54 651 19,231 103,108 Mar 13 04:40 PM Owens Bradley R. National Group President Mar 11 '24 Sale 29.49 632 18,638 81,121 Mar 13 04:41 PM Burkhalter Danielle Chief Human Resources Officer Mar 11 '24 Sale 29.59 127 3,758 36,465 Mar 13 04:41 PM TAPARO ANTHONY Chief Growth Officer Mar 05 '24 Sale 30.70 1,347 41,353 103,759 Mar 06 04:54 PM Evans Jason Eric Chief Executive Officer Mar 04 '24 Sale 30.61 9,070 277,633 466,494 Mar 06 04:52 PM Bane Harrison R. American Group President Mar 04 '24 Sale 30.53 5,104 155,825 53,310 Mar 06 04:53 PM Doherty David T Chief Financial Officer Mar 04 '24 Sale 30.37 3,426 104,048 96,440 Mar 06 04:53 PM Baldock Jennifer Chief Admin & Dev Officer Mar 04 '24 Sale 30.73 2,318 71,232 185,241 Mar 06 04:54 PM Owens Bradley R. National Group President Mar 04 '24 Sale 30.43 1,658 50,453 81,753 Mar 06 04:54 PM Brittenham Marissa Chief Strategy Officer Mar 04 '24 Sale 30.17 1,284 38,738 39,768 Mar 06 04:53 PM Burkhalter Danielle Chief Human Resources Officer Mar 04 '24 Sale 30.41 586 17,820 36,592 Mar 06 04:53 PM Burkhalter Danielle Chief Human Resources Officer Feb 14 '24 Sale 33.42 192 6,417 30,444 Feb 16 04:17 PM TAPARO ANTHONY Chief Growth Officer Feb 13 '24 Sale 33.40 1,100 36,740 91,315 Feb 14 04:24 PM Evans Jason Eric Chief Executive Officer Feb 12 '24 Sale 35.08 5,780 202,762 419,118 Feb 14 04:32 PM Baldock Jennifer Chief Admin & Dev Officer Feb 12 '24 Sale 34.83 1,115 38,835 87,333 Feb 14 04:26 PM Owens Bradley R. National Group President Feb 12 '24 Sale 35.22 1,040 36,629 73,149 Feb 14 04:29 PM Doherty David T Chief Financial Officer Feb 12 '24 Sale 34.93 1,020 35,629 74,209 Feb 14 04:34 PM Burkhalter Danielle Chief Human Resources Officer Feb 06 '24 Sale 32.24 167 5,384 30,636 Feb 08 05:03 PM Doherty David T Chief Financial Officer Feb 02 '24 Sale 31.89 2,306 73,538 75,229 Feb 06 04:08 PM Brittenham Marissa Chief Strategy Officer Feb 02 '24 Sale 31.89 1,637 52,204 30,469 Feb 06 04:11 PM DeVeydt Wayne S Exec Chairman of the Board Dec 19 '23 Option Exercise 12.90 100,000 1,290,000 300,000 Dec 21 05:17 PM O'Reilly T. Devin Director Dec 19 '23 Sale 33.44 7,826,870 261,730,533 50,421,379 Dec 21 08:21 PM Kaplan Andrew T. Director Dec 19 '23 Sale 33.44 7,826,870 261,730,533 50,421,379 Dec 21 08:29 PM BAIN CAPITAL INVESTORS LLC Director Dec 19 '23 Sale 33.44 7,826,870 261,730,533 50,421,379 Dec 21 08:13 PM HENDRIX BLAIR E Director Dec 19 '23 Sale 33.44 7,826,870 261,730,533 50,421,379 Dec 21 08:17 PM DeVeydt Wayne S Exec Chairman of the Board Dec 19 '23 Sale 33.44 168,130 5,622,267 131,870 Dec 21 05:17 PM Evans Jason Eric Chief Executive Officer Dec 19 '23 Sale 33.44 5,000 167,200 419,898 Dec 21 05:17 PM Bane Harrison R. American Group President Sep 05 '23 Sale 35.98 3,835 137,995 46,709 Sep 05 04:05 PM Doherty David T Chief Financial Officer Aug 30 '23 Sale 36.12 2,000 72,242 77,535 Sep 01 04:11 PM Doherty David T Chief Financial Officer Aug 29 '23 Sale 35.21 202 7,113 79,535 Sep 01 04:11 PM Evans Jason Eric Chief Executive Officer Jun 29 '23 Sale 45.10 1,892 85,329 424,898 Jul 03 01:17 PM Owens Bradley R. National Group President May 17 '23 Sale 36.31 7,191 261,105 74,189 May 18 05:19 PM
Index RUT P/E - EPS (ttm) -2.67 Insider Own 52.09% Shs Outstand 181.36M Perf Week 0.19%
Market Cap 7.74B Forward P/E - EPS next Y -2.79 Insider Trans -0.48% Shs Float 87.15M Perf Month 0.90%
Income -432.84M PEG - EPS next Q -0.64 Inst Own 48.52% Short Float 9.09% Perf Quarter 1.67%
Sales 0.00M P/S - EPS this Y 6.16% Inst Trans 4.98% Short Ratio 5.63 Perf Half Y 67.85%
Book/sh 3.71 P/B 11.45 EPS next Y -11.34% ROA -38.29% Short Interest 7.92M Perf Year 33.30%
Cash/sh 5.45 P/C 7.81 EPS next 5Y - ROE -72.44% 52W Range 19.59 - 43.59 Perf YTD 0.35%
Dividend Est. - P/FCF - EPS past 5Y - ROI -37.60% 52W High -2.39% Beta 1.47
Dividend TTM - Quick Ratio 10.92 Sales past 5Y 0.00% Gross Margin - 52W Low 117.20% ATR (14) 0.35
Dividend Ex-Date - Current Ratio 10.92 EPS Y/Y TTM -15.07% Oper. Margin 0.00% RSI (14) 58.87 Volatility 0.79% 0.83%
Employees 334 Debt/Eq 0.71 Sales Y/Y TTM - Profit Margin - Recom 2.67 Target Price 45.00
Option/Short Yes / Yes LT Debt/Eq 0.71 EPS Q/Q -28.02% Payout - Rel Volume 0.64 Prev Close 42.59
Sales Surprise - EPS Surprise 2.74% Sales Q/Q - Earnings Nov 01 BMO Avg Volume 1.41M Price 42.55
SMA20 0.99% SMA50 1.47% SMA200 28.45% Trades
Volume 907,408 Change -0.09%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-08-23 Downgrade TD Cowen
Outperform → Market Perform
$45
Nov-20-23 Resumed JP Morgan
Neutral
$25
Sep-28-23 Initiated Piper Sandler
Overweight
$33
Aug-03-23 Downgrade BofA Securities
Buy → Neutral
$36 → $31
May-04-23 Upgrade Wells Fargo
Equal Weight → Overweight
$30
Apr-10-23 Initiated TD Cowen
Outperform
Mar-17-23 Downgrade JP Morgan
Overweight → Neutral
$40 → $29
Mar-16-23 Resumed Berenberg
Hold
$22
Feb-23-23 Downgrade Wells Fargo
Overweight → Equal Weight
$38 → $30
Nov-01-22 Initiated Loop Capital
Buy
$40
Oct-20-22 Initiated BofA Securities
Buy
$39
Sep-29-22 Initiated Cantor Fitzgerald
Overweight
$41
Sep-26-22 Initiated Wells Fargo
Overweight
$38
Sep-13-22 Initiated Evercore ISI
Outperform
Jul-07-22 Initiated Mizuho
Neutral
$30
Feb-15-22 Initiated Goldman
Neutral
$27
Jan-05-22 Initiated JP Morgan
Overweight
$50
Dec-16-21 Initiated H.C. Wainwright
Buy
$50
Jun-18-21 Initiated Morgan Stanley
Overweight
$27
Dec-10-20 Initiated Goldman
Buy
$24
Show Previous Ratings
Apr-18-24 12:18PM
(The Wall Street Journal)
06:30AM
Mar-17-24 08:50AM
Jan-29-24 02:23PM
Jan-24-24 09:45AM
08:30AM
Loading…
08:30AM
Jan-23-24 02:45PM
Jan-02-24 06:10PM
Dec-08-23 07:00AM
(The Wall Street Journal)
Dec-07-23 04:20PM
(The Wall Street Journal) +11.37%
12:53PM
(The Wall Street Journal)
10:04AM
Dec-06-23 04:46PM
(The Wall Street Journal)
04:30PM
Nov-29-23 06:30AM
06:30AM
Loading…
Nov-08-23 06:30AM
Nov-01-23 09:14AM
06:30AM
Oct-13-23 06:30AM
Oct-11-23 10:45PM
04:01PM
Aug-29-23 06:30AM
Aug-11-23 02:21PM
Aug-08-23 06:28AM
Aug-02-23 06:30AM
Jul-05-23 06:30AM
Jun-15-23 06:30AM
May-10-23 06:30AM
May-03-23 06:30AM
Apr-26-23 10:01AM
06:30AM
Loading…
06:30AM
Apr-11-23 06:30AM
Mar-21-23 06:30AM
Mar-02-23 06:30AM
Feb-22-23 06:30AM
Feb-01-23 06:30AM
Jan-09-23 06:30AM
Jan-04-23 06:30AM
Dec-31-22 07:55AM
Dec-19-22 06:30AM
Dec-15-22 06:30PM
Nov-11-22 06:30AM
Nov-08-22 06:30AM
Oct-19-22 06:30AM
Sep-06-22 06:30AM
Aug-12-22 06:00AM
06:00AM
Aug-10-22 04:01PM
04:01PM
Aug-01-22 06:15AM
Jul-25-22 05:00PM
Jun-15-22 06:30AM
May-25-22 06:30AM
May-11-22 07:38AM
May-10-22 06:30AM
Apr-28-22 06:00AM
Apr-13-22 06:30AM
Mar-31-22 06:30AM
Mar-21-22 06:30AM
Mar-01-22 06:30AM
Feb-16-22 06:30AM
Feb-15-22 12:50PM
06:30AM
Jan-10-22 06:30AM
Jan-06-22 09:38AM
Jan-03-22 07:00AM
Dec-21-21 05:50AM
Dec-16-21 07:00AM
Nov-10-21 06:30AM
Nov-01-21 06:30AM
Oct-20-21 06:30AM
Oct-07-21 07:00AM
Sep-21-21 05:00PM
Sep-15-21 12:11PM
12:09PM
Sep-10-21 07:00AM
Sep-01-21 07:00AM
Aug-12-21 10:37AM
Aug-11-21 06:30AM
Aug-02-21 01:04PM
Jul-30-21 07:00AM
Jul-22-21 07:00AM
Jul-01-21 09:50PM
Jun-29-21 04:24PM
06:30AM
Jun-24-21 01:44AM
Jun-23-21 07:49PM
Jun-15-21 07:00AM
May-27-21 07:00AM
May-17-21 06:30AM
06:15AM
May-04-21 07:00AM
Apr-29-21 07:00AM
Apr-21-21 07:00AM
Apr-13-21 06:30AM
Mar-24-21 06:30AM
06:15AM
Mar-22-21 07:00AM
Feb-24-21 07:00AM
Jan-29-21 12:14AM
Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
COLES N ANTHONY Director Apr 01 '24 Option Exercise 3.50 50,000 175,000 65,638 Apr 03 04:15 PM COLES N ANTHONY Director Apr 01 '24 Sale 42.33 50,000 2,116,640 15,638 Apr 03 04:15 PM COLES N ANTHONY Director Mar 04 '24 Option Exercise 3.50 50,000 175,000 65,638 Mar 06 04:15 PM COLES N ANTHONY Director Mar 04 '24 Sale 41.01 50,000 2,050,550 15,638 Mar 06 04:15 PM COLES N ANTHONY Director Feb 29 '24 Option Exercise 3.50 50,000 175,000 65,638 Mar 04 05:49 PM COLES N ANTHONY Director Feb 29 '24 Sale 41.16 50,000 2,057,890 15,638 Mar 04 05:49 PM COLES N ANTHONY Director Feb 07 '24 Sale 41.54 2,506 104,110 15,638 Feb 08 07:14 PM Renger John Chief Scientific Officer Feb 07 '24 Sale 41.54 2,161 89,777 6,370 Feb 08 07:19 PM COLES N ANTHONY Director Jan 02 '24 Option Exercise 3.50 50,000 175,000 52,704 Jan 04 04:15 PM COLES N ANTHONY Director Jan 02 '24 Sale 42.24 50,000 2,111,815 2,704 Jan 04 04:15 PM Sanchez Ramiro Chief Medical Officer Dec 26 '23 Option Exercise 3.50 10,000 35,000 24,673 Dec 28 04:15 PM Tregoning Kathleen See Remarks Dec 26 '23 Option Exercise 10.05 3,150 31,658 10,666 Dec 28 04:15 PM Sanchez Ramiro Chief Medical Officer Dec 26 '23 Sale 42.47 10,000 424,700 14,673 Dec 28 04:15 PM DiPietro Kenneth Chief Human Resources Officer Dec 22 '23 Option Exercise 3.50 8,000 28,000 32,663 Dec 27 04:15 PM DiPietro Kenneth Chief Human Resources Officer Dec 22 '23 Sale 41.45 8,000 331,608 24,663 Dec 27 04:15 PM ALTSCHULLER Susan Chief Financial Officer Dec 20 '23 Sale 41.42 13,808 571,972 16,913 Dec 21 08:12 PM Sanchez Ramiro Chief Medical Officer Dec 20 '23 Sale 41.42 10,152 420,528 14,673 Dec 21 08:14 PM Bodenrader Mark See Remarks Dec 20 '23 Sale 41.42 7,889 326,788 17,724 Dec 21 08:27 PM Akamine Scott Chief Legal Officer Dec 20 '23 Sale 41.42 7,072 292,945 7,237 Dec 21 08:21 PM Tregoning Kathleen See Remarks Dec 20 '23 Sale 41.42 6,288 260,469 7,516 Dec 21 08:10 PM DiPietro Kenneth Chief Human Resources Officer Dec 20 '23 Sale 41.42 6,256 259,144 24,663 Dec 21 08:24 PM Sanchez Ramiro Chief Medical Officer Dec 15 '23 Option Exercise 9.88 7,500 74,100 7,500 Dec 19 04:15 PM Sanchez Ramiro Chief Medical Officer Dec 15 '23 Sale 41.39 7,500 310,393 0 Dec 19 04:15 PM Akamine Scott Chief Legal Officer Dec 07 '23 Option Exercise 13.17 10,000 131,700 10,513 Dec 07 07:45 PM Sanchez Ramiro Chief Medical Officer Dec 07 '23 Option Exercise 3.50 10,000 35,000 10,000 Dec 11 04:17 PM Sanchez Ramiro Chief Medical Officer Dec 07 '23 Sale 41.37 10,000 413,700 0 Dec 11 04:17 PM Akamine Scott Chief Legal Officer Dec 07 '23 Sale 41.37 10,000 413,700 513 Dec 07 07:45 PM Akamine Scott Chief Legal Officer Dec 05 '23 Option Exercise 13.17 7,500 98,775 8,013 Dec 07 07:45 PM Akamine Scott Chief Legal Officer Dec 05 '23 Sale 35.00 7,500 262,500 513 Dec 07 07:45 PM COLES N ANTHONY Director Nov 14 '23 Option Exercise 3.50 22,824 79,884 25,528 Nov 16 04:15 PM COLES N ANTHONY Director Nov 14 '23 Sale 25.13 22,824 573,455 2,704 Nov 16 04:15 PM COLES N ANTHONY Director Nov 08 '23 Option Exercise 3.50 100 350 2,804 Nov 09 05:03 PM COLES N ANTHONY Director Nov 08 '23 Sale 25.16 100 2,516 2,704 Nov 09 05:03 PM COLES N ANTHONY Director Nov 07 '23 Option Exercise 3.50 27,076 94,766 29,780 Nov 09 05:03 PM COLES N ANTHONY Director Nov 07 '23 Sale 25.02 27,076 677,555 2,704 Nov 09 05:03 PM COLES N ANTHONY Director Nov 03 '23 Option Exercise 3.50 61,401 214,904 64,105 Nov 06 05:12 PM COLES N ANTHONY Director Nov 03 '23 Sale 25.43 61,401 1,561,458 2,704 Nov 06 05:12 PM COLES N ANTHONY Director Nov 02 '23 Option Exercise 3.50 38,599 135,096 41,303 Nov 06 05:12 PM COLES N ANTHONY Director Nov 02 '23 Sale 25.19 38,599 972,239 2,704 Nov 06 05:12 PM PATRICK DEVAL L Director Nov 01 '23 Option Exercise 12.62 30,130 380,241 33,412 Nov 03 04:15 PM PATRICK DEVAL L Director Nov 01 '23 Sale 25.00 30,130 753,250 3,282 Nov 03 04:15 PM BAIN CAPITAL INVESTORS LLC 10% Owner Oct 16 '23 Buy 22.81 5,480,052 124,999,986 65,679,781 Oct 18 04:30 PM Koppel Adam Director Oct 16 '23 Buy 22.81 5,480,052 124,999,986 65,679,781 Oct 18 04:30 PM Gordon Christopher R Director Oct 16 '23 Buy 22.81 5,480,052 124,999,986 65,679,781 Oct 18 04:30 PM PERCEPTIVE ADVISORS LLC Director Oct 16 '23 Buy 22.81 876,808 19,999,990 10,794,876 Oct 17 04:53 PM COLES N ANTHONY Director Sep 07 '23 Option Exercise 3.50 50,000 175,000 52,704 Sep 08 04:35 PM COLES N ANTHONY Director Sep 07 '23 Sale 24.07 50,000 1,203,415 2,704 Sep 08 04:35 PM Burgess Paul D. See Remarks Aug 04 '23 Buy 22.93 21,880 501,794 21,880 Aug 07 05:11 PM Renaud Ronald C JR President & CEO Aug 03 '23 Buy 23.96 83,857 2,008,811 83,857 Aug 07 05:13 PM COLES N ANTHONY Director Jul 11 '23 Option Exercise 3.50 50,000 175,000 52,704 Jul 13 05:41 PM COLES N ANTHONY Director Jul 11 '23 Sale 30.03 50,000 1,501,340 2,704 Jul 13 05:41 PM DEKKERS MARIJN E Director Jun 15 '23 Sale 34.43 200,000 6,886,000 402,326 Jun 20 04:56 PM Bodenrader Mark See Remarks Jun 02 '23 Sale 32.95 1,895 62,440 5,522 Jun 05 08:07 PM COLES N ANTHONY CEO and Chairperson Jun 01 '23 Option Exercise 3.50 50,000 175,000 52,704 Jun 05 08:12 PM COLES N ANTHONY CEO and Chairperson Jun 01 '23 Sale 32.60 50,000 1,630,070 2,704 Jun 05 08:12 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
